za hirurgiju glave i vrata, medicinski fakultet u Novom Sadu 3 ORL odeljenje Kliničko bolnički ce... more za hirurgiju glave i vrata, medicinski fakultet u Novom Sadu 3 ORL odeljenje Kliničko bolnički centar Kosovska Mitrovica AUTORI SAŽETAK ENGLISH ORIGINALNI RADOVI Uvod: Efikasnost primenjenog modela lečenja laringealnog karcinoma meri se pojavom recidiva. Pojava recidiva značajno smanjuje preživljavanje i određuje tip naknadnog tretmana. Cilj: Utvrditi učestalost pojave recidiva karcinoma larinksa, mesto recidiviranja i definitivni tretman recidiva laringealnog karcinoma u odnosu na primenjene različite tipove hirurškog lečenja. Rezultati: Analizirano je 844 ispitanika sa primarno operisanim planocelularnim laringealnim karcinomom u periodu od 2002. godine do 2017. godine. Recidiv se razvio kod 191/844 (22.6%) ispitanika. Prosečno vreme do rezvoja recidiva iznosi 12.6 meseci. Supraglotisni karcinom češće daju recidive u odnosu na glotisne 35.93%/17.46%, p=0.000. Kod N0 vrata pojava recidiva je u 14.42% a kod N+ vrata u 45.91, p=0.000. Sa porastom stadijuma bolesti raste i broj recidiva, p=0.000. Najčešće mesto recidiviranja je vrat sa 45%, zatim lokalni recidiv sa 25.1%. Recidiv se najčešće javlja kod ispitanika sa načinjenom totalnom laringektomijom i parcijalnim faringektomijom 50%. Najučestaliji razvoj regionalnog recidiva je kod N3 kategorije i ekstrakapsularnog širenja, 72.7%. Definitivni tretman recidiva najčešće podrazumeva radikalnu disekciju vrata, i totalnu laringektomiju. Ispitanici sa pojavom recidiva imaju značajno niže trogodišnje ukupno preživljavanje u odnosu na one bez pojave recidiva 47.6%/92.3%, p=0.000. Zaključak: Pojava recidiva je očekivana kod svakog četvrtog bolesnika u prvih 36 meseci nakon primenjenog bilo kog tipa hirurškog tretmana karicinoma larinksa. Efikasnost lečenja je u direktnoj vezi sa pojavom recidiva. Recidivi se češće javljaju kod viših stadijuma bolesti, ekstrakapsularnog širenja i prisutnih metastaza na vratu. Recidivi značajno smanjuju ukupno preživljavanje bolesnika sa laringealnim karcinomom.
Introduction: The efficacy of the applied model of laryngeal cancer treatment is measured by recu... more Introduction: The efficacy of the applied model of laryngeal cancer treatment is measured by recurrence. Recurrence significantly reduces survival and determines the type of subsequent treatment. Objective: To determine the incidence of laryngeal cancer recurrence, the location of recurrence, and the definitive treatment of laryngeal cancer recurrence concerning different types of surgical treatments applied. Results: In the period from 2002 to 2017, 844 subjects with primary operated laryngeal squamous cell carcinoma were analyzed. Recurrence developed in 191/844 (22.6%) subjects. The mean recurrence time is 12.6 months. Supraglottic carcinoma is more likely to recur than glottic carcinoma 35.93% / 17.46%, p = 0.000. In N0 necks the recurrence rate is 14.42% and in N + necks it is 45.91, p = 0.000. In more advanced stages of the disease, the number of recurrence increases, p = 0.000. The most common area of recurrence is the neck with 45%, followed by local recurrence with 25.1%. R...
Loss of voice after total laryngectomy propter laryngeal cancer disables a person to successfully... more Loss of voice after total laryngectomy propter laryngeal cancer disables a person to successfully communicate with patient environment and can lead to total isolation. Learning esophageal speech in some cases is not successful. Vocal prosthesis insertion can resolve this condition. This retrospective study shows voice and speech rehabilitation in patients after total laryngectomy and installation of voice prostheses. The study included 48 patients (7 women, 41 men) with vocal prosthesis placement. Patients were 44-77years old (mean 62.5). In 7 patients (14.58%) underwent primary installation, and 41 (85.42%) patients with secondary installation of a voice prosthesis. The results of comparative analysis of four basic parameters of voice was found that the maximum phonation time of tracheoesophageal speech (12.5s) shorter than the normal speech (23.5s), and longer compared with esophageal speech (3s). Height tracheoesophageal voice (70-190Hz) is lower than the normal level of voice (150-220Hz) and higher compared with the amount of esophageal voice (70Hz). While the tracheoesophageal voice and speech needs more time for saying 120 phonetically balanced words (2.20min) than normal voice and speech (1.08min) and shorter than esophageal speech (3.05min). Conclusion: Tracheoesophageal voice and speech with voice prosthesis placement have extremely high success rate (98%), faster rehabilitation and better functional results than esophageal speech.
A prominent ear, so called a protruding or "lop" ear, is the most common congenital deformity of ... more A prominent ear, so called a protruding or "lop" ear, is the most common congenital deformity of the external ear. This deformity persists when the mastoid-helix angle (MHA) is higher than 30 degrees. It is relatively common among the population with the incidence of about 5%. The aim of this study is to present surgical procedure and our results using otoplasty with scoring anterior surface of the auricular cartilage. To analyze objective and subjective surgical procedure effects. Between 2011 and 2014 we treated 28 patients. We found statistically high significance p<0.01 in value mastoid-helix angle (MHA) preoperative and postoperative. In patients with bilateral otoplasty the difference between left and right MHAs after surgical procedure is less than 4 degrees. The difference of head-helix distance (HHD) preoperative and postoperative is statistically important with high significance p<0.05. Preoperative satisfaction by personal appearance was better after surgical procedure p<0.05. Complications occurred in 9 cases (32.4%). Otoplasty by scoring anterior surface of auricular cartilage is safe procedure for correction of prominent ear with excellent results on patient satisfaction by personal appearance. Effect of reducing the MHA and HHD is long lasting.
Introduction. The aim of this study was to present oncological and functional results of surgical... more Introduction. The aim of this study was to present oncological and functional results of surgical treatment of the base of tongue cancer by analyzing retrospectively 115 patients treated during a ten-year period. During this period, 150 patients with cancer of the base of tongue were diagnosed, which accounts for 5.6% of all diagnosed head and neck cancers and 24.1% of all oropharyngeal cancers. In 111 patients (96.5%), planocellular carcinoma with various degrees of differentiation was pathohistologically verified. Neck metastases were found in 88 (76.5%) patients. Advanced III and IV stages of disease were verified in 92.9% of patients (stage III in 23.4%, IV A in 59.1%, IV % B in 10.4%). Transmandibular approach was performed in 5.2% of patients, while 94.8% of patients were approached through pharynx The defects were covered by primary reconstruction; the pectoralis major myocutaneous flap was used in 4 patients . During immediate postoperative period, 17 (14.7%) patients develo...
za hirurgiju glave i vrata, medicinski fakultet u Novom Sadu 3 ORL odeljenje Kliničko bolnički ce... more za hirurgiju glave i vrata, medicinski fakultet u Novom Sadu 3 ORL odeljenje Kliničko bolnički centar Kosovska Mitrovica AUTORI SAŽETAK ENGLISH ORIGINALNI RADOVI Uvod: Efikasnost primenjenog modela lečenja laringealnog karcinoma meri se pojavom recidiva. Pojava recidiva značajno smanjuje preživljavanje i određuje tip naknadnog tretmana. Cilj: Utvrditi učestalost pojave recidiva karcinoma larinksa, mesto recidiviranja i definitivni tretman recidiva laringealnog karcinoma u odnosu na primenjene različite tipove hirurškog lečenja. Rezultati: Analizirano je 844 ispitanika sa primarno operisanim planocelularnim laringealnim karcinomom u periodu od 2002. godine do 2017. godine. Recidiv se razvio kod 191/844 (22.6%) ispitanika. Prosečno vreme do rezvoja recidiva iznosi 12.6 meseci. Supraglotisni karcinom češće daju recidive u odnosu na glotisne 35.93%/17.46%, p=0.000. Kod N0 vrata pojava recidiva je u 14.42% a kod N+ vrata u 45.91, p=0.000. Sa porastom stadijuma bolesti raste i broj recidiva, p=0.000. Najčešće mesto recidiviranja je vrat sa 45%, zatim lokalni recidiv sa 25.1%. Recidiv se najčešće javlja kod ispitanika sa načinjenom totalnom laringektomijom i parcijalnim faringektomijom 50%. Najučestaliji razvoj regionalnog recidiva je kod N3 kategorije i ekstrakapsularnog širenja, 72.7%. Definitivni tretman recidiva najčešće podrazumeva radikalnu disekciju vrata, i totalnu laringektomiju. Ispitanici sa pojavom recidiva imaju značajno niže trogodišnje ukupno preživljavanje u odnosu na one bez pojave recidiva 47.6%/92.3%, p=0.000. Zaključak: Pojava recidiva je očekivana kod svakog četvrtog bolesnika u prvih 36 meseci nakon primenjenog bilo kog tipa hirurškog tretmana karicinoma larinksa. Efikasnost lečenja je u direktnoj vezi sa pojavom recidiva. Recidivi se češće javljaju kod viših stadijuma bolesti, ekstrakapsularnog širenja i prisutnih metastaza na vratu. Recidivi značajno smanjuju ukupno preživljavanje bolesnika sa laringealnim karcinomom.
Introduction: The efficacy of the applied model of laryngeal cancer treatment is measured by recu... more Introduction: The efficacy of the applied model of laryngeal cancer treatment is measured by recurrence. Recurrence significantly reduces survival and determines the type of subsequent treatment. Objective: To determine the incidence of laryngeal cancer recurrence, the location of recurrence, and the definitive treatment of laryngeal cancer recurrence concerning different types of surgical treatments applied. Results: In the period from 2002 to 2017, 844 subjects with primary operated laryngeal squamous cell carcinoma were analyzed. Recurrence developed in 191/844 (22.6%) subjects. The mean recurrence time is 12.6 months. Supraglottic carcinoma is more likely to recur than glottic carcinoma 35.93% / 17.46%, p = 0.000. In N0 necks the recurrence rate is 14.42% and in N + necks it is 45.91, p = 0.000. In more advanced stages of the disease, the number of recurrence increases, p = 0.000. The most common area of recurrence is the neck with 45%, followed by local recurrence with 25.1%. R...
Loss of voice after total laryngectomy propter laryngeal cancer disables a person to successfully... more Loss of voice after total laryngectomy propter laryngeal cancer disables a person to successfully communicate with patient environment and can lead to total isolation. Learning esophageal speech in some cases is not successful. Vocal prosthesis insertion can resolve this condition. This retrospective study shows voice and speech rehabilitation in patients after total laryngectomy and installation of voice prostheses. The study included 48 patients (7 women, 41 men) with vocal prosthesis placement. Patients were 44-77years old (mean 62.5). In 7 patients (14.58%) underwent primary installation, and 41 (85.42%) patients with secondary installation of a voice prosthesis. The results of comparative analysis of four basic parameters of voice was found that the maximum phonation time of tracheoesophageal speech (12.5s) shorter than the normal speech (23.5s), and longer compared with esophageal speech (3s). Height tracheoesophageal voice (70-190Hz) is lower than the normal level of voice (150-220Hz) and higher compared with the amount of esophageal voice (70Hz). While the tracheoesophageal voice and speech needs more time for saying 120 phonetically balanced words (2.20min) than normal voice and speech (1.08min) and shorter than esophageal speech (3.05min). Conclusion: Tracheoesophageal voice and speech with voice prosthesis placement have extremely high success rate (98%), faster rehabilitation and better functional results than esophageal speech.
A prominent ear, so called a protruding or "lop" ear, is the most common congenital deformity of ... more A prominent ear, so called a protruding or "lop" ear, is the most common congenital deformity of the external ear. This deformity persists when the mastoid-helix angle (MHA) is higher than 30 degrees. It is relatively common among the population with the incidence of about 5%. The aim of this study is to present surgical procedure and our results using otoplasty with scoring anterior surface of the auricular cartilage. To analyze objective and subjective surgical procedure effects. Between 2011 and 2014 we treated 28 patients. We found statistically high significance p<0.01 in value mastoid-helix angle (MHA) preoperative and postoperative. In patients with bilateral otoplasty the difference between left and right MHAs after surgical procedure is less than 4 degrees. The difference of head-helix distance (HHD) preoperative and postoperative is statistically important with high significance p<0.05. Preoperative satisfaction by personal appearance was better after surgical procedure p<0.05. Complications occurred in 9 cases (32.4%). Otoplasty by scoring anterior surface of auricular cartilage is safe procedure for correction of prominent ear with excellent results on patient satisfaction by personal appearance. Effect of reducing the MHA and HHD is long lasting.
Introduction. The aim of this study was to present oncological and functional results of surgical... more Introduction. The aim of this study was to present oncological and functional results of surgical treatment of the base of tongue cancer by analyzing retrospectively 115 patients treated during a ten-year period. During this period, 150 patients with cancer of the base of tongue were diagnosed, which accounts for 5.6% of all diagnosed head and neck cancers and 24.1% of all oropharyngeal cancers. In 111 patients (96.5%), planocellular carcinoma with various degrees of differentiation was pathohistologically verified. Neck metastases were found in 88 (76.5%) patients. Advanced III and IV stages of disease were verified in 92.9% of patients (stage III in 23.4%, IV A in 59.1%, IV % B in 10.4%). Transmandibular approach was performed in 5.2% of patients, while 94.8% of patients were approached through pharynx The defects were covered by primary reconstruction; the pectoralis major myocutaneous flap was used in 4 patients . During immediate postoperative period, 17 (14.7%) patients develo...
Uploads
Papers by Jugoslav Gasic